Neutral impactSector

India's solar cell capacity surge may squeeze margins, favour integrated manufacturers: Report

BusinessLine 27 min ago·20 Nov 2026, 5:52 am

India's solar industry is rapidly expanding its manufacturing base, with capacity expected to hit 124 gigawatts by FY27. This surge is driven by strong domestic demand, which is projected to reach only 60 GW during the same period. Consequently, the market is likely to see a significant oversupply of solar cells, the core component of the panels.

This oversupply creates a challenging environment for standalone cell manufacturers. With excess inventory, they may struggle to maintain pricing power, which could compress profit margins. In contrast, integrated manufacturers, who control both cell production and module assembly, are better positioned to manage these costs and maintain stability.

For investors, the key takeaway is a shift in market dynamics. While the sector remains attractive due to the 'Make in India' push, the focus should be on companies with integrated operations. Investors should monitor inventory levels and pricing trends to gauge how well manufacturers are navigating this period of rapid capacity growth.

Excerpt from BusinessLine

Cell capacity seen at 124 GW by FY27 against 60 GW demand; DCR module prices already declining: YES Securities India’s solar manufacturing sector is heading towards a major shift as fresh domestic cell capacity is expected to ease supply shortages and reduce the premium earned by manufacturers using locally produced…
Read the original at BusinessLine

Key takeaways

  • Category: Sector.
  • Assessed as a significant, market-relevant update.

Why it matters

A meaningful update worth tracking. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at BusinessLine.

More Sector news

More news

Latest headlines

More news

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.

India's solar cell capacity surge may squeeze margins, favour integrated manufacturers: Report